膜黑色素瘤治疗:一个更新
Alison Hiong1,2, Darvy Dang3,4, Malaka Ameratunga1,2
1Department of Medical Oncology, Alfred Health, Melbourne, Australia.
Clinical & experimental ophthalmology
|February 3, 2026
概括
卵巢黑色素瘤治疗提供局部控制,但面临转移和生活质量方面的挑战. 未来的管理可能涉及新的向疗法和免疫疗法,以获得更好的结果.
科学领域:
- 眼科医生 眼科 眼科
- 在瘤学瘤学.
- 医学研究 医学研究
背景情况:
- 卵膜黑色素瘤是一种罕见的眼睛黑色素细胞的癌症.
- 目前的放射治疗和手术等治疗方法都有局限性,包括视力丧失和高转移性复发率.
- 转移阶段的预后不好,尽管有现有的治疗方法,但生存率有限.
研究的目的:
- 提供当前阴道黑色素瘤治疗策略的最新信息.
- 探索新兴疗法的潜力,以管理毛膜黑色素瘤.
- 讨论在线膜黑色素瘤管理的未来方向.
主要方法:
- 对原发性和转移性皮膜黑色素瘤的当前治疗选择的审查.
- 讨论新的向疗法和免疫疗法.
- 探索新辅助疗法概念的探索.
主要成果:
- 已建立的治疗方法可以实现局部控制,但与显著的副作用和转移性进展有关.
- 现有的全身疗法,包括免疫检查点抑制剂和tebentafusp,在延长转移性皮膜黑色素瘤的存活时间方面表现出有限的有效性.
- 新兴的治疗途径有望改善患者的治疗结果.
结论:
- 人们迫切需要更有效的治疗线膜黑色素瘤,特别是在转移性环境中.
- 新型向疗法,先进的免疫疗法和新辅助方法对于推进皮膜黑色素瘤管理至关重要.
- 未来的研究应该专注于整合这些新的策略,以改善皮膜黑色素瘤患者的生存率和生活质量.
相关概念视频
Open Angle Glaucoma: Treatment
999
In open-angle glaucoma, the iridocorneal angle remains open, but the trabecular meshwork becomes stiff, slowing down the outflow of aqueous humor. This causes a buildup of aqueous humor in the anterior chamber, leading to a sudden increase in intraocular pressure. The treatment for open-angle glaucoma focuses on reducing the elevated intraocular pressure by either decreasing the secretion of aqueous humor or increasing its outflow.
Drugs such as carbonic anhydrase inhibitors, α2- and...
Drugs such as carbonic anhydrase inhibitors, α2- and...
999
Treatment Resistant Cancers
3.8K
Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...
3.8K
Parkinson's Disease: Treatment
1.2K
Neurodegenerative disorders, such as Parkinson's Disease (PD), involve the gradual and irreversible destruction of neurons in particular brain areas. These disorders exhibit standard features like proteinopathies, selective vulnerability of some neurons, and an interaction of intrinsic properties, genetics, and environmental influences in neural injury.
Parkinson's Disease is primarily a result of the loss of dopaminergic neurons in the substantia nigra pars compacta. The cornerstone of...
Parkinson's Disease is primarily a result of the loss of dopaminergic neurons in the substantia nigra pars compacta. The cornerstone of...
1.2K
Alzheimer's Disease: Treatment
956
Alzheimer's Disease (AD), a neurodegenerative disorder, is pathologically identified by amyloid plaques and neurofibrillary tangles composed of tau protein. AD pharmacotherapy aims to manage cognitive symptoms, delay disease progression, and treat behavioral symptoms. The treatment is primarily symptomatic and palliative, with no definitive disease-modifying therapy available. Cholinesterase inhibitors, including donepezil (Aricept), rivastigmine (Exelon), and galantamine (Razadyne), are...
956
Anticholinesterase Agents: Poisoning and Treatment
1.6K
Anticholinesterases, also known as cholinesterase inhibitors, work by blocking the breakdown of acetylcholine, leading to its accumulation in the synaptic cleft. This accumulation indirectly enhances both muscarinic and nicotinic actions. These agents are classified as reversible or irreversible based on their mechanism of action.
Irreversible agents form a strong bond with the cholinesterase enzyme, making it inactive. The breakdown of the phosphorylated enzyme is...
Irreversible agents form a strong bond with the cholinesterase enzyme, making it inactive. The breakdown of the phosphorylated enzyme is...
1.6K
Angle Closure Glaucoma: Treatment
1.3K
Angle-closure glaucoma, or closed-angle glaucoma, is an eye condition where the iris bulges out and blocks the iridocorneal angle, resulting in a buildup of aqueous humor and increased intraocular pressure. Immediate medical attention is necessary due to the sudden onset of symptoms. The treatment for angle-closure glaucoma includes short-term and long-term approaches. Short-term treatment involves using eye drops like pilocarpine to lower intraocular pressure by increasing aqueous humor...
1.3K


